|
MAP3K7 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.045100E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.098200E-02 |
| Normal-vs-Stage2 |
8.260600E-03 |
| Normal-vs-Stage3 |
1.029460E-04 |
| Normal-vs-Stage4 |
1.047400E-04 |
| Stage1-vs-Stage2 |
1.990630E-01 |
| Stage1-vs-Stage3 |
3.204100E-02 |
| Stage1-vs-Stage4 |
1.976490E-02 |
| Stage2-vs-Stage3 |
7.905600E-01 |
| Stage2-vs-Stage4 |
5.501600E-01 |
| Stage3-vs-Stage4 |
6.528200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.010500E-04 |
| Normal-vs-AfricanAmerican |
1.635800E-02 |
| Normal-vs-Asian |
5.820200E-01 |
| Caucasian-vs-AfricanAmerican |
9.261200E-01 |
| Caucasian-vs-Asian |
1.393640E-01 |
| AfricanAmerican-vs-Asian |
1.576960E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.019930E-04 |
| Normal-vs-Female |
7.861000E-03 |
| Male-vs-Female |
2.094000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.752300E-02 |
| Normal-vs-Age(41-60Yrs) |
7.643400E-03 |
| Normal-vs-Age(61-80Yrs) |
1.368980E-04 |
| Normal-vs-Age(81-100Yrs) |
4.750100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.983600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.933200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.729800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.936830E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.499800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.500000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.451800E-01 |
| Normal-vs-Grade 2 |
4.167700E-02 |
| Normal-vs-Grade 3 |
2.11079999999919E-05 |
| Normal-vs-Grade 4 |
5.99980000000055E-05 |
| Grade 1-vs-Grade 2 |
2.498800E-01 |
| Grade 1-vs-Grade 3 |
2.832000E-02 |
| Grade 1-vs-Grade 4 |
1.686060E-02 |
| Grade 2-vs-Grade 3 |
9.696300E-03 |
| Grade 2-vs-Grade 4 |
6.899900E-03 |
| Grade 3-vs-Grade 4 |
3.460600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.475800E-02 |
| Normal-vs-ccB subtype |
1.895050E-03 |
| ccA subtype-vs-ccB subtype |
1.174750E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.819700E-03 |
| Normal-vs-N1 |
8.654500E-02 |
| N0-vs-N1 |
2.435400E-01 |
|
|
